CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Open-market sale Chief Business Officer sold 6,945 shares at $31.53 ($218,968)
- 4 Option exercise Chief Medical Officer acquired 7,500 shares (option exercise)
- 4 Open-market sale EVP, Research & CSO sold 2,930 shares at $30.00 ($87,900)
- 4 Open-market sale EVP, Research & CSO sold 2,340 shares at $27.29 ($63,848)
- 4 Option exercise Chief Medical Officer acquired 20,000 shares (option exercise)
- 4 Open-market sale EVP, Research & CSO sold 2,340 shares at $26.26 ($61,448)
- 8-K Event Material agreement
- S-3ASR Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Medical Officer sold 5,000 shares at $31.44 ($157,209)
- 4 Open-market sale Chief Business Officer sold 6,944 shares at $31.27 ($217,153)
- 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $35.04 ($133,335)
- 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $35.49 ($443,608)
- 4 Open-market sale EVP, Research & CSO sold 5,560 shares at $43.03 ($239,236)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
Page 32 of 41 · 806 filings